These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16713701)

  • 1. In vitro evaluation of N-methyl amide tripeptidomimetics as substrates for the human intestinal di-/tri-peptide transporter hPEPT1.
    Andersen R; Nielsen CU; Begtrup M; Jørgensen FS; Brodin B; Frokjaer S; Steffansen B
    Eur J Pharm Sci; 2006 Jul; 28(4):325-35. PubMed ID: 16713701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and evaluation of tripeptidic promoieties targeting the intestinal peptide transporter hPEPT1.
    Thorn K; Andersen R; Christensen J; Jakobsen P; Nielsen CU; Steffansen B; Begtrup M
    ChemMedChem; 2007 Apr; 2(4):479-87. PubMed ID: 17407174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a QSAR model for binding of tripeptides and tripeptidomimetics to the human intestinal di-/tripeptide transporter hPEPT1.
    Andersen R; Jørgensen FS; Olsen L; Våbenø J; Thorn K; Nielsen CU; Steffansen B
    Pharm Res; 2006 Mar; 23(3):483-92. PubMed ID: 16489544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidomimetic ketomethylene isosteres as pro-moieties for drug transport via the human intestinal di-/tripeptide transporter hPEPT1: design, synthesis, stability, and biological investigations.
    Våbenø J; Nielsen CU; Ingebrigtsen T; Lejon T; Steffansen B; Luthman K
    J Med Chem; 2004 Sep; 47(19):4755-65. PubMed ID: 15341490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta- and gamma-di- and tripeptides as potential substrates for the oligopeptide transporter hPepT1.
    Hubatsch I; Arvidsson PI; Seebach D; Luthman K; Artursson P
    J Med Chem; 2007 Oct; 50(21):5238-42. PubMed ID: 17887660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipeptide derivatives of AZT: synthesis, chemical stability, activation in human plasma, hPEPT1 affinity, and antiviral activity.
    Santos C; Morais J; Gouveia L; de Clercq E; Pannecouque C; Nielsen CU; Steffansen B; Moreira R; Gomes P
    ChemMedChem; 2008 Jun; 3(6):970-8. PubMed ID: 18389514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line.
    Guo A; Hu P; Balimane PV; Leibach FH; Sinko PJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):448-54. PubMed ID: 10087037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phe-Gly dipeptidomimetics designed for the di-/tripeptide transporters PEPT1 and PEPT2: synthesis and biological investigations.
    Våbenø J; Lejon T; Nielsen CU; Steffansen B; Chen W; Ouyang H; Borchardt RT; Luthman K
    J Med Chem; 2004 Feb; 47(4):1060-9. PubMed ID: 14761208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tandem chain extension aldol reaction used for synthesis of ketomethylene tripeptidomimetics targeting hPEPT1.
    Thorn K; Nielsen CU; Jakobsen P; Steffansen B; Zercher CK; Begtrup M
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4597-601. PubMed ID: 21703856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quantitative structure-activity relationship for translocation of tripeptides via the human proton-coupled peptide transporter, hPEPT1 (SLC15A1).
    Omkvist DH; Larsen SB; Nielsen CU; Steffansen B; Olsen L; Jørgensen FS; Brodin B
    AAPS J; 2010 Sep; 12(3):385-96. PubMed ID: 20449699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bioactive dipeptide anserine is transported by human proton-coupled peptide transporters.
    Geissler S; Zwarg M; Knütter I; Markwardt F; Brandsch M
    FEBS J; 2010 Feb; 277(3):790-5. PubMed ID: 20067523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrimidine and nucleoside gamma-esters of L-Glu-Sar: synthesis, stability and interaction with hPEPT1.
    Eriksson AH; Elm PL; Begtrup M; Brodin B; Nielsen R; Steffansen B
    Eur J Pharm Sci; 2005 May; 25(1):145-54. PubMed ID: 15854810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity and translocation relationships via hPEPT1 of H-X aa-Ser-OH dipeptides: evaluation of H-Phe-Ser-OH as a pro-moiety for ibuprofen and benzoic acid prodrugs.
    Omkvist DH; Trangbæk DJ; Mildon J; Paine JS; Brodin B; Begtrup M; Nielsen CU
    Eur J Pharm Biopharm; 2011 Feb; 77(2):327-31. PubMed ID: 21147219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hPEPT1 affinity and translocation of selected Gln-Sar and Glu-Sar dipeptide derivatives.
    Eriksson AH; Elm PL; Begtrup M; Nielsen R; Steffansen B; Brodin B
    Mol Pharm; 2005; 2(3):242-9. PubMed ID: 15934785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor and insulin short-term increase hPepT1-mediated glycylsarcosine uptake in Caco-2 cells.
    Nielsen CU; Amstrup J; Nielsen R; Steffansen B; Frokjaer S; Brodin B
    Acta Physiol Scand; 2003 Jun; 178(2):139-48. PubMed ID: 12780388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro characterization of human peptide transporter hPEPT1 interactions and passive permeation studies of short cationic antimicrobial peptides.
    Flaten GE; Kottra G; Stensen W; Isaksen G; Karstad R; Svendsen JS; Daniel H; Svenson J
    J Med Chem; 2011 Apr; 54(7):2422-32. PubMed ID: 21401113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell line.
    Nielsen CU; Andersen R; Brodin B; Frokjaer S; Taub ME; Steffansen B
    J Control Release; 2001 Sep; 76(1-2):129-38. PubMed ID: 11532319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational restrictions in ligand binding to the human intestinal di-/tripeptide transporter: implications for design of hPEPT1 targeted prodrugs.
    Våbenø J; Nielsen CU; Steffansen B; Lejon T; Sylte I; Jørgensen FS; Luthman K
    Bioorg Med Chem; 2005 Mar; 13(6):1977-88. PubMed ID: 15727852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of ligands for the human intestinal Di-/Tripeptide transporter (hPEPT1) using a QSAR-assisted virtual screening strategy.
    Larsen SB; Omkvist DH; Brodin B; Nielsen CU; Steffansen B; Olsen L; Jørgensen FS
    ChemMedChem; 2009 Sep; 4(9):1439-45. PubMed ID: 19557803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling of the intestinal peptide transporter hPepT1 and analysis of its transport capacities by docking and pharmacophore mapping.
    Pedretti A; De Luca L; Marconi C; Negrisoli G; Aldini G; Vistoli G
    ChemMedChem; 2008 Dec; 3(12):1913-21. PubMed ID: 18979492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.